Daxor Net Income 2010-2011 | DXR

Daxor net income from 2010 to 2011. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Daxor Annual Net Income
(Millions of US $)
2011 $-7
2010 $5
2009 $6
Daxor Quarterly Net Income
(Millions of US $)
2011-12-31 $-1
2011-09-30 $-4
2011-06-30 $0
2011-03-31 $-1
2010-12-31 $2
2010-09-30 $3
2010-06-30 $0
2010-03-31 $0
2009-12-31 $-1
2009-09-30 $3
2009-06-30 $6
2009-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.045B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.462B 19.18
Encompass Health (EHC) United States $12.251B 25.97
DaVita (DVA) United States $10.411B 14.64
Chemed (CHE) United States $8.228B 25.86
Elanco Animal Health (ELAN) United States $6.903B 14.79
Option Care Health (OPCH) United States $5.224B 23.28
RadNet (RDNT) United States $4.401B 279.29
Amedisys (AMED) United States $3.081B 20.73
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.081B 22.85
Astrana Health (ASTH) United States $1.416B 35.08
U.S Physical Therapy (USPH) United States $1.174B 30.29
Aveanna Healthcare Holdings (AVAH) United States $1.075B 61.22
Pennant (PNTG) United States $1.019B 37.41
Atai Life Sciences (ATAI) Germany $0.483B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.045B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00